Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4), commonly known as BRG1, is the ATPase core of the SWI/SNF chromatin remodeling complex. This protein plays a critical role in modifying chromatin structure to regulate the accessibility of DNA for transcription, replication, repair, and recombination. Possessing both ATPase and bromodomain motifs, SMARCA4 binds nucleosomes and reads epigenetic marks. It acts as a tumor suppressor and is frequently mutated or deleted in diverse cancers, including rhabdoid tumors, lung adenocarcinoma, and small cell carcinoma of the ovary. Germline or somatic alterations in SMARCA4 disrupt normal cell differentiation, cycles, and proliferation, giving rise to developmental syndromes and predisposing to aggressive tumors. Current therapeutic interest focuses on exploiting vulnerabilities in SMARCA4-mutant cancers, using epigenetic/kinase inhibitors or immunomodulatory approaches, since direct reactivation of SMARCA4 function is not yet feasible
Modulation of chromatin remodeling to restore transcriptional regulation; Synthetic lethality induction (e.g., DNA damage repair inhibition with ATR inhibitors or platinum agents); Epigenetic modification inhibition (e.g., BET, EZH2, HDAC inhibitors); Immune activation (immune checkpoint blockade)
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4 (SMARCA4 (commonly known as BRG1)).